FAK is at the crossroads of integrin and growth factors signalling and, as FAK is overexpressed in many human cancers, FAK is frequently associated with the promotion of oncogenic signals and the inhibition of tumour suppressive pathways. The gene discussed is PTK2; the disease is cancer.